本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Anaptysbio Inc

21.19
-0.5100-2.35%
盤後21.190.00000.00%16:05 EDT
成交量:29.44萬
成交額:631.50萬
市值:6.50億
市盈率:-4.14
高:21.90
開:21.88
低:21.15
收:21.70
資料載入中...
2022/03/21

重要事件披露

8-K - Current report
2022/03/14

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/30

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/30

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/04

重要事件披露

8-K - Current report
2021/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/25

重要事件披露

8-K - Current report